As Ohio’s overdose epidemic has climbed toward a record high, an army of lobbyists representing makers of prescription painkillers and their allies poured more than $3.5 million into Ohio political coffers. Pharmaceutical companies and allied groups belonging to the Pain …
Johnson & Johnson persuaded a New Jersey judge to throw out two women’s lawsuits blaming the health-care company’s talcum powder for their ovarian cancer. The ruling may help J&J fend off more than 1,000 suits in state and federal courts …
California has accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices. According to the lawsuit filed by the state’s attorney general on Tuesday, J&J and …
Johnson & Johnson must pay $55 million to a 62-year-old South Dakota woman who blamed her ovarian cancer on the company’s talcum powder in the second such trial loss this year. J&J is accused in more than 1,000 lawsuits in …
Johnson & Johnson was ordered to pay $502 million to a group of patients who accused the company of hiding flaws in its Pinnacle artificial hips that caused the devices to prematurely fail and left them facing surgeries and pain, …
Johnson & Johnson must pay $72 million to the family of a woman who blamed her fatal ovarian cancer on the company’s talcum powder in the first state-court case over the claims to go to trial. Jurors in St. Louis …
Johnson & Johnson defeated a lawsuit claiming it had improperly designed its Tylenol pain reliever in the first case to go to trial over the link between the widely used over-the-counter drug and liver damage, according to a J&J spokesman. …
Managing general agency Johnson & Johnson, Inc. (J&J) has acquired John Handel & Associates, Inc. (JHA), located in St. Petersburg, Fla. Under its new ownership, JHA will continue to offer the same products and services throughout the state of Florida, …
South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. The decision was to substitute the same verdict the court reached in February in order to correct a …
South Carolina’s Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury’s finding that the drugmaker’s Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier …
